CD8A and COVID-19: However, in two-dose-vaccinated and boosted female COVID-19+ subject #17, the percentage of TRM within CD8+CD3+IFN-γ+ showed 20.83- and 6.67-fold increase following M-peptide and N-peptide exposures, respectively (Figure 3S).